Nadav Kidron - 17 Mar 2026 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
President and CEO, Director
Signature
/s/ Nadav Kidron
Issuer symbol
ORMP
Transactions as of
17 Mar 2026
Net transactions value
$0
Form type
4
Filing time
18 Mar 2026, 17:46:36 UTC
Previous filing
16 Mar 2026
Next filing
18 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KIDRON NADAV President and CEO, Director 1185 AVENUE OF THE AMERICAS, THIRD FLOOR, NEW YORK /s/ Nadav Kidron 18 Mar 2026 0001351779

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award +167,005 +5.1% $0.000000* 3,422,243 17 Mar 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs"). The RSUs will vest ratably in 8 quarterly installments beginning April 1, 2026. Each RSU represents the right to receive one share of common stock, par value $0.012 per share, of the Issuer.